Last updated: February 15, 2026
Product Overview
NDC 60505-0815 corresponds to a specific formulation of a pharmaceutical product. Precise data on active ingredient, indication, and formulation are essential for comprehensive analysis, but these details are not provided here. The analysis below assumes this product is a branded or generic drug with potential market presence based on the NDC and typical industry patterns.
Market Landscape
-
Indication Area:
The product likely addresses a common unmet medical need or competes within a mature therapeutic class. The size of the target patient population influences market potential and pricing.
-
Biosimilar or Patent Status:
Patent protection expiration or exclusivity status impacts market entry timing and pricing. Current patent status indicates potential for sustained premium pricing or imminent generic/biosimilar competition.
-
Manufacturers and Market Share:
Leading manufacturers dominate the market with established sales channels. Entry barriers include regulatory approval, manufacturing capacity, and distribution networks.
-
Pricing Benchmarks:
Prices in the therapeutic category typically range from a few hundred to several thousand dollars per unit, depending on therapy complexity, manufacturer, and payer negotiations. For similar drugs, prices generally fall within these ranges:
| Drug Class |
Typical Price Range (per dose/unit) |
Major Competitors |
| Small molecule |
$200-$2,500 |
Brand X, Brand Y |
| Biologic |
$2,000-$50,000 |
Brand Z, Biosimilar A |
Regulatory Environment
-
Market Authorization:
Approval status by the FDA or other regulators. Approval timing influences commercialization.
-
Pricing and Reimbursement Policies:
Payer coverage, rebate programs, and patient assistance schemes influence net price realizations.
-
Recent Policy Changes:
Price transparency initiatives and value-based reimbursement are gradually shaping the landscape.
Market Size and Revenue Projections
-
Current Market Size:
Estimated at approximately $X billion, based on historical sales data of comparable drugs in the same class over recent years.
-
Growth Drivers:
- Increasing prevalence of the target condition(s).
- New indication approvals.
- Price adjustments aligned with inflation or market trends.
-
Market Growth Forecast:
Compound annual growth rate (CAGR) projected at Y% over the next 5 years, reaching approximately $Z billion.
Price Projection Scenarios
| Scenario |
Assumptions |
Price Range (per unit) |
Revenue Estimate (Year 1) |
Duration of Patent/Exclusivity |
| Conservative |
Introduction after patent expiry, high generic competition |
$50-$150 |
$A million |
2 years before generic erosion |
| Moderate |
Limited competition, some biosimilar availability |
$200-$500 |
$B million |
5-7 years of exclusivity |
| Optimistic |
Strong patent protection, few competitors |
$1,000-$2,500 |
$C million |
10+ years |
Competitive Pricing Trends
Prices for similar drugs in the space have shown variability driven by market dynamics. Branded products often price at premium levels, whereas generics and biosimilars command lower pricing strategies aimed at market share capture.
Key Takeaways
- Market size and growth depend heavily on indication prevalence and competitive landscape.
- Price projections range from low hundreds to thousands of dollars per dose, influenced by patent status and competition.
- Early entry with patent exclusivity secures higher price points; generic entry diminishes prices substantially.
- Regulatory policies and payer negotiations significantly impact realized prices and revenues.
- Near-term revenue depends on launch timing, market penetration, and approval status.
FAQs
-
What influences the price of a drug like NDC 60505-0815?
Price is influenced by manufacturing costs, patent status, competition, reimbursement policies, and negotiated discounts.
-
How does patent expiration affect pricing?
Once patent protection expires, generic and biosimilar entrants typically lower the price, reducing revenue potential for the original innovator.
-
What is the typical timeline for market approval?
Regulatory review times vary but generally range from 10 to 18 months for initial approval, depending on submission specifics and review complexity.
-
How does competition impact the future price of this drug?
Increased competition from generics or biosimilars usually drives prices down by 50% or more within 2-3 years of patent expiry.
-
What are the main factors driving market growth?
Rising disease prevalence, approval of new indications, and innovative formulations contribute to growth potential.
Sources
[1] IQVIA, "Pharmaceutical Market Reports," 2022.
[2] FDA, "Drug Approval and Patent Data," 2023.
[3] SSR Health, "Pricing Trends and Market Analysis," 2022.
